Age-related macular degeneration?(AMD) is a?disease?leading to severe visual loss?and?legal blindness in the elderly population.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Age-Related Macular Degeneration (AMD) Therapeutics industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Wet AMD
Dry AMD
Market Segment by Product Application
Hospital
Clinic
Research Institute
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Amgen Inc.
Bausch Health Companies, Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Age-Related Macular Degeneration (AMD) Therapeutics consumption (value) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
2.To understand the structure of Age-Related Macular Degeneration (AMD) Therapeutics market by identifying its various subsegments.
3.Focuses on the key global Age-Related Macular Degeneration (AMD) Therapeutics manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Age-Related Macular Degeneration (AMD) Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Age-Related Macular Degeneration (AMD) Therapeutics submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Age-Related Macular Degeneration (AMD) Therapeutics Market Research Report 2021, Forecast to 2026
1 Market Study Overview
1.1 Study Objectives
1.2 Age-Related Macular Degeneration (AMD) Therapeutics Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Age-Related Macular Degeneration (AMD) Therapeutics Segment by Type
2.1.1 Wet AMD
2.1.2 Dry AMD
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Clinic
2.2.3 Research Institute
2.2.4 Other
2.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Comparison by Regions (2016-2026)
2.3.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2016-2026)
2.3.2 North America Age-Related Macular Degeneration (AMD) Therapeutics Status and Prospect (2016-2026)
2.3.3 Europe Age-Related Macular Degeneration (AMD) Therapeutics Status and Prospect (2016-2026)
2.3.4 China Age-Related Macular Degeneration (AMD) Therapeutics Status and Prospect (2016-2026)
2.3.5 Japan Age-Related Macular Degeneration (AMD) Therapeutics Status and Prospect (2016-2026)
2.3.6 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Age-Related Macular Degeneration (AMD) Therapeutics Industry Impact
2.5.1 Age-Related Macular Degeneration (AMD) Therapeutics Business Impact Assessment - Covid-19
2.5.2 Market Trends and Age-Related Macular Degeneration (AMD) Therapeutics Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Age-Related Macular Degeneration (AMD) Therapeutics Manufacturer Market Share
3.5 Top 10 Age-Related Macular Degeneration (AMD) Therapeutics Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Age-Related Macular Degeneration (AMD) Therapeutics Market
3.7 Key Manufacturers Age-Related Macular Degeneration (AMD) Therapeutics Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Age-Related Macular Degeneration (AMD) Therapeutics Industry Key Manufacturers
4.1 Amgen Inc.
4.1.1 Compan Detail
4.1.2 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Introduction, Application and Specification
4.1.3 Amgen Inc. 137 Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 Amgen Inc. News
4.2 Bausch Health Companies, Inc.
4.2.1 Compan Detail
4.2.2 Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Product Introduction, Application and Specification
4.2.3 Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 Amgen Inc. News
4.3 F. Hoffmann-La Roche Ltd.
4.3.1 Compan Detail
4.3.2 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Product Introduction, Application and Specification
4.3.3 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 F. Hoffmann-La Roche Ltd. News
4.4 Novartis AG
4.4.1 Compan Detail
4.4.2 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product Introduction, Application and Specification
4.4.3 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 Novartis AG News
4.5 Regeneron Pharmaceuticals Inc.
4.5.1 Compan Detail
4.5.2 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Product Introduction, Application and Specification
4.5.3 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 Regeneron Pharmaceuticals Inc. News
5 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Segment by Big Type
5.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue, Sales and Market Share by Big Type (2016-2021)
5.1.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales and Market Share by Big Type (2016-2021)
5.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Market Share by Big Type (2016-2021)
5.2 Wet AMD Sales Growth Rate and Price
5.2.1 Global Wet AMD Sales Growth Rate (2016-2021)
5.2.2 Global Wet AMD Price (2016-2021)
5.3 Dry AMD Sales Growth Rate and Price
5.3.1 Global Dry AMD Sales Growth Rate (2016-2021)
5.3.2 Global Dry AMD Price (2016-2021)
6 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Segment by Big Application
6.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Big Application (2016-2021)
6.2 Hospital Sales Growth Rate (2016-2021)
6.3 Clinic Sales Growth Rate (2016-2021)
6.4 Research Institute Sales Growth Rate (2016-2021)
6.5 Other Sales Growth Rate (2016-2021)
7 Global Age-Related Macular Degeneration (AMD) Therapeutics Forecast
7.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue, Sales and Growth Rate (2021-2026)
7.2 Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast by Regions (2021-2026)
7.2.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast (2021-2026)
7.2.2 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast (2021-2026)
7.2.3 China Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast (2021-2026)
7.2.4 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast (2021-2026)
7.2.5 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast (2021-2026)
7.2.6 Other Regions Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast (2021-2026)
7.3 Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast by Type (2021-2026)
7.3.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Type (2021-2026)
7.3.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share Forecast by Type (2021-2026)
7.4 Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast by Application (2021-2026)
7.4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Application (2021-2026)
7.4.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share Forecast by Application (2021-2026)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Age-Related Macular Degeneration (AMD) Therapeutics Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Age-Related Macular Degeneration (AMD) Therapeutics Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Age-Related Macular Degeneration (AMD) Therapeutics
Figure Market Concentration Ratio and Market Maturity Analysis of Age-Related Macular Degeneration (AMD) Therapeutics
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Big Type
Figure Global Market Share of Age-Related Macular Degeneration (AMD) Therapeutics by Big Type in 2020
Figure Wet AMD Picture (2016-2021)
Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Big Application
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Big Application in 2020
Figure Hospital Picture
Figure Clinic Picture
Figure Research Institute Picture
Figure Other Picture
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Comparison by Regions (M USD) ?2016-2026?
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size (Million US$) (2016-2026)
Figure North America Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million US$) Growth Rate (2016-2026)
Figure China Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million US$) Growth Rate (2016-2026)
Figure Japan Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million US$) Growth Rate (2016-2026)
Figure Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and Age-Related Macular Degeneration (AMD) Therapeutics Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Manufacturer (2016-2021)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Manufacturer in 2020
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Manufacturer (2016-2021)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Manufacturer in 2020
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Age-Related Macular Degeneration (AMD) Therapeutics Manufacturer (Revenue) Market Share in 2020
Figure Top 10 Age-Related Macular Degeneration (AMD) Therapeutics Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into Age-Related Macular Degeneration (AMD) Therapeutics Market
Table Key Manufacturers Age-Related Macular Degeneration (AMD) Therapeutics Product Type
Table Mergers & Acquisitions Planning
Table Amgen Inc. Company Profile
Table Age-Related Macular Degeneration (AMD) Therapeutics Product Introduction, Application and Specification of Amgen Inc.
Table Age-Related Macular Degeneration (AMD) Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2016-2021
Table Company One Main Business
Table Company One Recent Development
Table Bausch Health Companies, Inc. Company Profile
Table Age-Related Macular Degeneration (AMD) Therapeutics Product Introduction, Application and Specification of Bausch Health Companies, Inc.
Table Age-Related Macular Degeneration (AMD) Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Bausch Health Companies, Inc. Recent Development
Table F. Hoffmann-La Roche Ltd. Company Profile
Table Age-Related Macular Degeneration (AMD) Therapeutics Product Introduction, Application and Specification of F. Hoffmann-La Roche Ltd.
Table Age-Related Macular Degeneration (AMD) Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table F. Hoffmann-La Roche Ltd. Main Business
Table F. Hoffmann-La Roche Ltd. Recent Development
Table Novartis AG Company Profile
Table Age-Related Macular Degeneration (AMD) Therapeutics Product Introduction, Application and Specification of Novartis AG
Table Age-Related Macular Degeneration (AMD) Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Novartis AG Main Business
Table Novartis AG Recent Development
Table Novartis AG Main Business
Table Novartis AG Recent Development
Table Regeneron Pharmaceuticals Inc. Company Profile
Table Age-Related Macular Degeneration (AMD) Therapeutics Product Introduction, Application and Specification of Regeneron Pharmaceuticals Inc.
Table Age-Related Macular Degeneration (AMD) Therapeutics Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Regeneron Pharmaceuticals Inc. Main Business
Table Regeneron Pharmaceuticals Inc. Recent Development
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2016-2021)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2016-2021)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Regions (2016-2021)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Regions in 2020
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Regions (2016-2021)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Regions in 2020
Figure North America Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2016-2021)
Figure Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2016-2021)
Figure China Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2016-2021)
Figure Japan Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2016-2021)
Figure Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2016-2021)
Figure Other Regions Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2016-2021)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Big Type (2016-2021)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Big Type (2016-2021)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Big Type in 2019
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Big Type (2016-2021)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Big Type (2016-2021)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Big Type in 2019
Figure Global Wet AMD Sales Growth Rate (2016-2021)
Figure Global Wet AMD Price (2016-2021)
Figure Global Dry AMD Sales Growth Rate (2016-2021)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Sales by Big Application (2016-2021)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Big Application (2016-2021)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Market Share by Big Application in 2019
Figure Global Hospital Sales Growth Rate (2016-2021)
Figure Global Clinic Sales Growth Rate (2016-2021)
Figure Global Research Institute Sales Growth Rate (2016-2021)
Figure Global Other Sales Growth Rate (2016-2021)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Sales and Growth Rate (2021-2026)
Figure Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue and Growth Rate (2021-2026)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Regions (2021-2026)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share Forecast by Regions (2021-2026)
Figure North America Sales Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast (2021-2026)
Figure Europe Sales Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast (2021-2026)
Figure China Sales Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast (2021-2026)
Figure Japan Sales Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast (2021-2026)
Figure Southeast Asia Sales Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast (2021-2026)
Figure Other Regions Sales Age-Related Macular Degeneration (AMD) Therapeutics Market Forecast (2021-2026)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Type (2021-2026)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share Forecast by Type (2021-2026)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Sales Forecast by Application (2021-2026)
Table Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share Forecast by Application (2021-2026)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Age-Related Macular Degeneration (AMD) Therapeutics
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Age-Related Macular Degeneration (AMD) Therapeutics Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Age-Related Macular Degeneration (AMD) Therapeutics Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Age-Related Macular Degeneration (AMD) Therapeutics Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Age-Related Macular Degeneration (AMD) Therapeutics Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Age-Related Macular Degeneration (AMD) Therapeutics Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Amgen Inc.
Bausch Health Companies, Inc.
F. Hoffmann-La Roche Ltd.
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)